The Trump MFN EO: Terrible as a Policy Prescription … but Solid as a PR Stunt
Shares:
APEX | Obesity Grabs the Headlines: Looking at a Novo Formulary Win and a New Paper on Budget Impact
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
I know there are some new readers today, and, in the interest of expectation-setting, I wanted to reassure them that the newsletter isn’t usually this long. But I’ve been thinking
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.